Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02227628 · ClinicalTrials.gov registry record · NA
Absorption and Antioxidant Effects of Polyphenolics From Acai
A NA study, sponsored by Texas A&M University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02227628 is a NA study that has completed, run by Texas A&M University. The registered enrollment target is 50 participants.
The verdict
NCT02227628, a NA study, has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
A human clinical consumption trial will be performed in volunteers with increased risk factors for cardiovascular disease (Metabolic Syndrome), which includes obesity and diabetes and related conditions over a period of 12 weeks with blood draws at baseline (0 weeks), 4, 8, and 12 weeks and a 24 hr urine collection on each blood draw day.
Interventions
- DIETARY_SUPPLEMENT Acai polyphenolics
- DIETARY_SUPPLEMENT Sugary Beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-04 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02227628
The ClinicalTrials.gov registry entry for NCT02227628 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acai polyphenolics is the first listed.
NCT02227628 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02227628 about?
NCT02227628 is a clinical study titled "Absorption and Antioxidant Effects of Polyphenolics From Acai". A human clinical consumption trial will be performed in volunteers with increased risk factors for cardiovascular disease (Metabolic Syndrome), which includes obesity and diabetes and related conditions over a period of 12 weeks with blood draws at baseline (0 weeks), 4, 8, and 12 weeks and a 24 hr ...
What is the current status of trial NCT02227628?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2013-04. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02227628?
The interventions under investigation include: Acai polyphenolics (DIETARY_SUPPLEMENT), Sugary Beverage (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02227628?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.